BioGX Moving to Expand Research and Development

BioGX, Inc. began their journey by developing tests for water quality, food safety, and pharma quality control. They have since expanded and become a leader in developing simple yet superior molecular diagnostics testing. They have stayed busy throughout the pandemic, dedicating time to developing COVID-19 tests. BioGX has just announced they will be moving locations to enhance this expansion.

Leaving their original headquarters, they will set up shop in a 30,000-square-foot, three-floor facility. This new facility will include office space as well as research and development labs and space to manufacture their products. They hope to continue expanding, and hopefully draw talent from local universities. Their recent innovations include a test which detects SARS-CoV-2 (Covid-19), Influenza A, Influenza B and Respiratory Syncytial Virus RNA in a single patient sample. 

Are you adapting technology for a new purpose? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at or contact your usual Swanson Reed representative.

Recent Posts